ARTICLE | Clinical News

Taxus Liberte: Additional data

October 4, 2010 7:00 AM UTC

Additional data from the ATLAS trial in 871 patients showed that Taxus Liberte and Taxus Express led to similar rates of target lesion revascularization (TLR) at 5 years (11% vs. 11.5%, p=0.72). Rates of cardiac death (5.1% vs. 4.4%, p=0.49), overall myocardial infarction (MI) (7.6% vs. 8.4%, p=0.57), and stent thrombosis (3% vs. 2.7%, p=0.76) were also similar between treatment arms at 5 years. Data were presented at the Transcatheter Cardiovascular Therapeutics meeting in Washington. ...